1. Home
  2. NEOV vs MOLN Comparison

NEOV vs MOLN Comparison

Compare NEOV & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEOV
  • MOLN
  • Stock Information
  • Founded
  • NEOV 2018
  • MOLN 2004
  • Country
  • NEOV United States
  • MOLN Switzerland
  • Employees
  • NEOV N/A
  • MOLN N/A
  • Industry
  • NEOV Industrial Machinery/Components
  • MOLN
  • Sector
  • NEOV Miscellaneous
  • MOLN
  • Exchange
  • NEOV Nasdaq
  • MOLN Nasdaq
  • Market Cap
  • NEOV 181.8M
  • MOLN 195.4M
  • IPO Year
  • NEOV N/A
  • MOLN 2021
  • Fundamental
  • Price
  • NEOV $3.67
  • MOLN $5.33
  • Analyst Decision
  • NEOV Strong Buy
  • MOLN
  • Analyst Count
  • NEOV 1
  • MOLN 0
  • Target Price
  • NEOV $7.50
  • MOLN N/A
  • AVG Volume (30 Days)
  • NEOV 303.0K
  • MOLN 6.1K
  • Earning Date
  • NEOV 02-07-2025
  • MOLN 03-13-2025
  • Dividend Yield
  • NEOV N/A
  • MOLN N/A
  • EPS Growth
  • NEOV N/A
  • MOLN N/A
  • EPS
  • NEOV N/A
  • MOLN N/A
  • Revenue
  • NEOV $2,471,178.00
  • MOLN $7,105,397.00
  • Revenue This Year
  • NEOV $85.10
  • MOLN N/A
  • Revenue Next Year
  • NEOV $281.25
  • MOLN $29.41
  • P/E Ratio
  • NEOV N/A
  • MOLN N/A
  • Revenue Growth
  • NEOV N/A
  • MOLN N/A
  • 52 Week Low
  • NEOV $0.63
  • MOLN $3.32
  • 52 Week High
  • NEOV $6.11
  • MOLN $12.70
  • Technical
  • Relative Strength Index (RSI)
  • NEOV 35.94
  • MOLN 49.14
  • Support Level
  • NEOV $3.57
  • MOLN $5.25
  • Resistance Level
  • NEOV $4.75
  • MOLN $5.33
  • Average True Range (ATR)
  • NEOV 0.46
  • MOLN 0.20
  • MACD
  • NEOV -0.13
  • MOLN 0.02
  • Stochastic Oscillator
  • NEOV 4.41
  • MOLN 44.23

About NEOV NeoVolta Inc.

NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: